首页 > 市场调查报告书 > 医疗设备

生技设备

微生物定序服务市场规模、份额和成长分析（按技术、应用、最终用户和地区划分）—产业预测（2026-2033 年）

市场调查报告书

商品编码

1898116

微生物定序服务市场规模、份额和成长分析（按技术、应用、最终用户和地区划分）—产业预测（2026-2033 年）

Microbiome Sequencing Services Market Size, Share, and Growth Analysis, By Technology (Sequencing By Synthesis, Sequencing By Ligation), By Application (Shotgun Sequencing, RNA Sequencing), By End User, By Region -Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，微生物组定序服务市场规模将达到 17 亿美元，到 2025 年将达到 18.9 亿美元，到 2033 年将达到 42.6 亿美元，在预测期（2026-2033 年）内，复合年增长率为 10.7%。

由于基因技术的进步以及人们对微生物组在人类健康中所扮演角色的认识不断加深，微生物组定序服务市场正经历显着增长。这激发了人们对个人化医疗的兴趣。越来越多的研究将微生物组与健康状况联繫起来，从而推动了消费者对人体微生物群落资讯的需求。因此，微生物组分析正成为治疗策略的重要组成部分，尤其是在新型微生物组标靶治疗方法不断出现的情况下。将微生物组定序与转录组学和代谢体学相结合的多体学学方法，正在增强研究能力，并揭示人类与细菌之间复杂的相互关係。此外，这个不断扩展的领域致力于利用先进的定序技术来揭示疾病关联，从而为更早、更准确的诊断铺平道路。微生物组定序的应用范围也在环境和农业研究领域不断扩大，进一步展现了其多功能性。

微生物组定序服务市场驱动因素

微生物组定序服务市场的扩张主要得益于人们对个人化医疗日益增长的关注。随着医疗保健不断向个人化治疗策略发展，微生物组分析透过提供每位患者体内微生物组成的具体讯息，发挥关键作用。这些宝贵的资讯能够提高诊断准确性和疾病管理效果，从而推动对个人化解决方案的需求不断增长。因此，医疗保健领域对微生物组分析的日益普及正在推动市场成长。这表明，微生物组分析在实现最佳患者疗效以及促进医学研究和治疗应用创新方面发挥着至关重要的作用。

微生物组定序服务市场限制因素

微生物组定序服务市场面临的一大挑战是相关技术的成本。儘管该领域已取得显着进展，但定序设备、试剂和分析流程带来的经济负担仍可能成为小规模研究机构和诊所的障碍。高成本可能会抑制它们有效采用和利用这些服务的能力，从而限制整体市场成长潜力。因此，微生物组定序服务的可负担性仍然是一个关键障碍，必须加以解决，才能促进这一快速成长的研究领域的更广泛应用和进一步发展。

微生物组定序服务市场趋势

微生物组定序服务市场正呈现出人工智慧 (AI) 和机器学习技术日益融合的显着趋势。这一发展趋势增强了对复杂微生物组数据的分析和解读能力，从而能够更精准地洞察微生物功能及其对健康和疾病预防的重要影响。透过简化数据处理流程并提升预测能力，人工智慧驱动的解决方案有助于制定个人化的健康策略和治疗性介入。对可靠且先进的微生物组分析工具的需求正在推动市场成长，而人工智慧则被视为加深我们对微生物组在人类健康中所扮演角色理解的关键推动因素。

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较
主要企业简介
- Charles River Laboratories
- Eurofins Scientific
- BGI
- Microbiome Insights Inc.
- MR DNA
- Baseclear BV
- Clinical Microbiomics AS
- Zymo Research
- Rancho Biosciences
- Metabiomics
- CosmosID
- ZIFO
- Shanghai Realbio Technology（RBT）Co., Ltd.
- Second Genome

结论与建议

简介目录

Product Code: SQMIG35J2091

Microbiome Sequencing Services Market size was valued at USD 1.7 Billion in 2024 and is poised to grow from USD 1.89 Billion in 2025 to USD 4.26 Billion by 2033, growing at a CAGR of 10.7% during the forecast period (2026-2033).

The microbiome sequencing services market is experiencing significant growth driven by advancements in genetic technology and a heightened understanding of the microbiome's role in human health, fostering interest in personalized medicine. Research linking the microbiome to health outcomes is increasing consumer demand for insights into the microbial communities within the body. Consequently, microbiome analysis is becoming integral to treatment strategies, particularly as new microbiome-targeted therapies emerge. The integration of multi-omics approaches, combining microbiome sequencing with transcriptomics and metabolomics, enhances research capabilities and emphasizes the intricate relationship between humans and bacteria. Furthermore, this expanding field focuses on utilizing advanced sequencing techniques for disease association, paving the way for earlier and more accurate diagnoses. Applications extend into environmental and agricultural studies, underscoring the versatility of microbiome sequencing.

Top-down and bottom-up approaches were used to estimate and validate the size of the Microbiome Sequencing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Microbiome Sequencing Services Market Segments Analysis

Global Microbiome Sequencing Services Market is segmented by service, technology, application, end user and region. Based on service, the market is segmented into Sample Preparation, Sequencing and Library Preparation, and Data Analysis. Based on technology, the market is segmented into sequencing by synthesis (SBS), sequencing by ligation (SBL), pyrosequencing, sanger sequencing and others. Based on application, the market is segmented into shotgun sequencing, targeted gene sequencing, RNA sequencing, whole genome sequencing and others. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, hospitals and clinics and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Microbiome Sequencing Services Market

The expansion of the microbiome sequencing services market is significantly influenced by the growing emphasis on personalized medicine. As healthcare continues to shift towards individualized treatment strategies, microbiome analysis plays a crucial role by delivering specific insights into the composition of microorganisms present in each patient. This valuable information enhances the accuracy of diagnoses and the effectiveness of condition management, contributing to a rising demand for tailored solutions. Consequently, the integration of microbiome analysis into healthcare practices is driving the market forward, highlighting its importance in achieving optimal patient outcomes and fostering innovation in medical research and therapeutic applications.

Restraints in the Microbiome Sequencing Services Market

A notable challenge facing the microbiome sequencing services market is the expense associated with these technologies. Despite considerable advancements in the field, the financial burden linked to sequencing equipment, reagents, and analytical processes can be prohibitive for smaller research institutions and clinics. This high cost can hinder their ability to adopt and utilize these services effectively, subsequently limiting the market's overall growth potential. Consequently, the affordability of microbiome sequencing services remains a critical barrier that must be addressed to facilitate broader access and encourage further development in this burgeoning area of research.

Market Trends of the Microbiome Sequencing Services Market

The microbiome sequencing services market is witnessing a notable trend characterized by the rising integration of Artificial Intelligence (AI) and machine learning technologies. This evolution enhances the analysis and interpretation of complex microbiome data, allowing for more precise insights into microbial functions and their substantial influences on health and disease prevention. As AI-driven solutions streamline data processing and improve predictive capabilities, they facilitate the development of personalized health strategies and therapeutic interventions. The demand for reliable and sophisticated microbiome analysis tools is driving market growth, positioning AI as a pivotal component in advancing our understanding of the microbiome's role in human health.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Patent Analysis
Case Studies

Global Microbiome Sequencing Services Market Size by Service & CAGR (2026-2033)

Market Overview
Sample Preparation
Sequencing and Library Preparation
Data Analysis

Global Microbiome Sequencing Services Market Size by Technology & CAGR (2026-2033)

Market Overview
Sequencing by Synthesis (SBS)
Sequencing by Ligation (SBL)
Pyrosequencing
Sanger Sequencing
Others

Global Microbiome Sequencing Services Market Size by Application & CAGR (2026-2033)

Market Overview
Shotgun Sequencing
Targeted Gene Sequencing
RNA Sequencing
Whole Genome Sequencing
Others

Global Microbiome Sequencing Services Market Size by End User & CAGR (2026-2033)

Market Overview
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Hospitals and Clinics
Others

Global Microbiome Sequencing Services Market Size & CAGR (2026-2033)

North America, (Service, Technology, Application, End User)
- US
- Canada
Europe, (Service, Technology, Application, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Service, Technology, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Service, Technology, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Service, Technology, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Charles River Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BGI
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microbiome Insights Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MR DNA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baseclear BV
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clinical Microbiomics AS
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zymo Research
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rancho Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Metabiomics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CosmosID
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZIFO
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shanghai Realbio Technology (RBT) Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Second Genome
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments